Skip to main content
Clinical Trials/KCT0002525
KCT0002525
Completed
未知

Human study for investigating the effectiveness and safety of Mulberry ethanol extract in adults whose fasting glucose is borderline.

Bundang Jesaeng Hospital0 sites70 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Bundang Jesaeng Hospital
Enrollment
70
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Bundang Jesaeng Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) Subject who voluntarily agrees to participate and sign in informed consent form
  • 2\) Adults (Age\=20 years)
  • 3\) Fasting blood glucose\=100 mg/dL and \=125 mg/d

Exclusion Criteria

  • 1\) Continuous consumption of drug, oriental medicine, dietary supplement those that affect glucose metabolism, antioxidant within 1 month before the first visit
  • 2\) Following diseases :
  • \- cardiac failure, coronary artery disease, uncontrolled hypertension (systolic blood pressure \=160 mmHg or diastolic blood pressure \=100 mmHg), hyperlipidemia, diabetes (fasting blood glucose \=126 mg / dL), renal dysfunction (rising more than 1\.5 times the upper limit of normal creatinine) Hepatic dysfunction (ALT, AST three times higher than normal upper limit), hypothyroidism, chronic gastrointestinal disorders, gastrointestinal surgery, acute and chronic inflammatory diseases, malignant tumors, Mental diseases, chronic or serious patients who need to take medication in the long term
  • 3\) BMI\=18\.5 kg/m2 or BMI\=30 kg/m2
  • 4\) Subjects who controlling body weight or subjects who have changed of body weight more than 10 percent within 6 months before the first visit
  • 5\) Excessive smoker (\= 20 cigarettes / day)
  • 6\) Alcoholics
  • 7\) Subjects with hypersensitivity to test materials
  • 8\) Participation in other human study within 1 month before the first visit
  • 9\) Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials